582
Participants
Start Date
September 3, 2024
Primary Completion Date
December 4, 2024
Study Completion Date
March 4, 2025
GR2001
The packaging for GR2001 injection uses a borosilicate glass vial, a brominated halobutyl rubber stopper for injectable solutions and an aluminum-plastic combination cap for antibiotic vials as its primary packaging materials. The specification is 5mg/1ml per vial.
HTIG
The HTIG is a Chinese licensed Human Tetanus Immunoglobulin produced by Tonglu-Bio, which are derived from human plasma, and then purified and filled in the injectable vial form.
RECRUITING
Peking University First Hospital, Beijing
RECRUITING
Peking University People Hospital, Beijing
RECRUITING
Beijing Tiantan Hospital, Beijing
RECRUITING
Huashan Hospital, Fudan University, Shanghai
RECRUITING
The Affiliated Hospital of Yangzhou University, Yangzhou
RECRUITING
The Second Affiliated Hospital of Anhui Medical University, Hefei
RECRUITING
Zhejiang Provincial People's Hospital, Hangzhou
RECRUITING
The Second Affiliated Hospital of Nanchang University, Nanchang
RECRUITING
Nanhua Hospital Affiliated to University of south China, Hengyang
RECRUITING
The Central Hospital of Wuhan, Wuhan
RECRUITING
Tongji Hospital, Tongji Medical College of HUST, Wuhan
RECRUITING
The First Affiliated Hospital of Guangzhou Medical University, Guangzhou
RECRUITING
The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou
RECRUITING
Zhujiang Hospital Affiliated to Southern Medical University, Guangzhou
RECRUITING
Shenzhen Second People's Hospital, Shenzhen
RECRUITING
Liuzhou People's Hospital, Liuzhou
RECRUITING
Liuzhou Workers's Hospital, Liuzhou
RECRUITING
The Affiliated Hospital of Zunyi Medical University, Zunyi
RECRUITING
Linfen Central Hospital, Linfen
RECRUITING
Yuncheng Central Hospital, Yuncheng
Genrix (Shanghai) Biopharmaceutical Co., Ltd.
INDUSTRY